PDCD1 and hepatocellular carcinoma: Moreover, recent studies have demonstrated the importance of immunological markers, including PD-1 and PD-L1, and tumor microenvironments (TMEs) such as regulatory T cells (Tregs) and cytotoxic T cells (CTLs), in the recurrence of HCC following curative treatments [24,25,26].